Connect with others who understand.

sign up log in
Resources
About MyMSTeam

Connect with others who understand.

sign up log in
Resources
About MyMSTeam
MULTIPLE SCLEROSIS
NEWS

Study Encourages Shared Decision-Making When Choosing Treatment for Children With MS

Posted on November 23, 2021
Medically reviewed by
Evelyn O. Berman, M.D.
Article written by
Torrey Kim

  • A recent study found that parents whose children have multiple sclerosis (MS) face challenges when selecting the right disease-modifying therapy (DMT).
  • The study found that just 44 percent of people who chose DMTs for their children were very satisfied with the treatment they selected.
  • These results suggest that health care providers should encourage shared decision-making to boost satisfaction among children with MS and their parents.

Parents of children and adolescents with multiple sclerosis often express dissatisfaction with the disease-modifying therapies they chose for their children, according to a recent study. The report revealed that just 44 percent of parents studied described themselves as “very satisfied” with the DMT they selected for their children with pediatric-onset MS (POMS) — also called pediatric MS.

Researchers found that the more control parents had over the DMT decision-making process, the higher their satisfaction rates. In addition, strong communication with doctors and feeling supported by their children’s health care providers also increased satisfaction.

Multiple sclerosis affects people under the age of 16 in about 3 percent to 5 percent of all MS cases. Those with POMS tend to experience more frequent relapses than adults with MS do, and the same DMTs prescribed to adults may also be recommended for children in some cases.

Children with POMS must rely on their parents to help select the most appropriate DMTs for treatment. However, because no standard approach exists to simplify this process, parents sometimes meet challenges when deciding on the right DMTs for their children.

The study’s authors suggested that health care providers take note of family values and preferences when helping parents choose a DMT for their child. Doctors could also point parents toward online decision-support tools, if necessary.

“There is an opportunity of health care providers to foster shared decision-making practices to improve satisfaction among parents of children and adolescents with POMS,” the authors noted.

Learn more about how MS treatment effectiveness is measured.

All updates must be accompanied by text or a picture.
Evelyn O. Berman, M.D. is a neurology and pediatric specialist and treats disorders of the brain in children. Review provided by VeriMed Healthcare Network. Learn more about her here.
Torrey Kim is a freelance writer with MyHealthTeam. Learn more about her here.

Related articles

Neuropathic pain is estimated to affect anywhere from 30 percent to 90 percent of people with...

Opioid Problems and MS

Neuropathic pain is estimated to affect anywhere from 30 percent to 90 percent of people with...
Many people with multiple sclerosis (MS) switch treatments over time.Before switching MS...

5 Things To Know When Switching MS Treatments

Many people with multiple sclerosis (MS) switch treatments over time.Before switching MS...
Cognitive symptoms such as impaired attention and memory occur in many people with multiple...

Strategies for Enhancing Cognitive Abilities With Multiple Sclerosis

Cognitive symptoms such as impaired attention and memory occur in many people with multiple...
Doctors measure the effectiveness of disease-modifying therapies (DMTs) in multiple sclerosis...

MS Treatment: How Is Effectiveness Measured?

Doctors measure the effectiveness of disease-modifying therapies (DMTs) in multiple sclerosis...
Switching disease-modifying therapies (DMTs) is common among people who are treating relapsing...

Switching MS Treatments: When and Why It Might Be Time To Switch

Switching disease-modifying therapies (DMTs) is common among people who are treating relapsing...
Highly effective (HE) disease-modifying treatments (DMTs) can help slow the progression of...

What Is Highly Effective Treatment for MS?

Highly effective (HE) disease-modifying treatments (DMTs) can help slow the progression of...

Recent articles

A person can develop multiple sclerosis (MS) at any age, but the condition is most often...

What Is the Average Age for a Multiple Sclerosis Diagnosis?

A person can develop multiple sclerosis (MS) at any age, but the condition is most often...
If you're living with multiple sclerosis (MS), you may wonder how moderate or heavy alcohol consumption could affect your disease and overall well-being.

MS and Alcohol: What Are the Effects?

If you're living with multiple sclerosis (MS), you may wonder how moderate or heavy alcohol consumption could affect your disease and overall well-being.
Multiple sclerosis (MS) is a neurological condition that disrupts the signals between your brain...

Bladder Spasms and MS: Understanding the Connection

Multiple sclerosis (MS) is a neurological condition that disrupts the signals between your brain...
Muscle spasms are common among people with multiple sclerosis (MS), and they can feel worse at...

Why Are MS Muscle Spasms Worse at Night?

Muscle spasms are common among people with multiple sclerosis (MS), and they can feel worse at...
In partnership with GoodRx
If you’re sensitive to temperatures — especially heat — and your multiple sclerosis (MS) symptoms...

MS and Fever: Managing Symptoms and Body Temperature

If you’re sensitive to temperatures — especially heat — and your multiple sclerosis (MS) symptoms...
MS News
MS News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close